Table 2.
Scores for the FAS, FS and RPE during the CMR and PLA trials
| |
|
|
|
Time point |
|
|
|---|---|---|---|---|---|---|
| Scale | Trial | Baseline | Section 1 | Section 2 | Section 3 | Section 4 |
| FS |
CHO |
1.1 ± 1.4 |
−0.3 ± 1.0 |
−0.8 ± 1.2 |
−1.1 ± 1.1 |
−0.9 ± 2.5 |
| PLA |
1.4 ± 1.2 |
−0.1 ± 0.8 |
0.0 ± 0.5 |
−0.5 ± 0.9 |
0.0 ± 1.2 |
|
| FAS |
CHO |
2.3 ± 0.5 |
2.6 ± 1.4 |
2.4 ± 1.3 |
2.5 ± 1.5 |
2.6 ± 1.2 |
| PLA |
2.0 ± 0.8 |
2.6 ± 1.3 |
2.3 ± 1.2 |
2.4 ± 1.5 |
2.8 ± 1.4 |
|
| RPE (6-20) |
CHO |
n/a |
13 ± 1 |
13 ± 1 |
14 ± 2* |
15 ± 2* |
| PLA | n/a | 12 ± 1 | 13 ± 1 | 14 ± 1* | 14 ± 2* |
* Significant within (i.e., time) effect noted for each group different to Section 1 (P < 0.05). No between group differences are otherwise noted. Data are mean ± SD.